[1]
Khan, A.R. et al. 2026. Comparison of Metformin Plus Modified-Release Gliclazide Versus Metformin Plus Sitagliptin in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial. Biological and Clinical Sciences Research Journal. 7, 3 (Mar. 2026), 51–54. DOI:https://doi.org/10.54112/bcsrj.v7i3.2192.